MLM Medical Labs and Amprion Announce Strategic Collaboration to Expand Access to α-Synuclein Testing in Europe
MLM and Amprion partner to expand access to breakthrough α-synuclein biomarker testing for European neurodegenerative clinical trials. MöNCHENGLADBACH, NORTH RHINE-WESTPHALIA, GERMANY, August 13, 2026 /EINPresswire.com/ -- MLM Medical Labs (MLM), a …